Nicorette 15 mg/16 h - transdermal patch, 14 ST

Image/color similar

Nicorette 15 mg/16 h - transdermal patch is a medicinal product used for smoking cessation. Nicorette contains nicotine as the active ingredient, which is released evenly and in a controlled manner through the skin over a period of 16 hours.

€41.96

% €52.45 (20% saved)

Content: 14 Stück (€3.00 / 1 Stück)

(May vary by country)

Ready to ship in 1-3 working days ⁴

Product number: RA3537433

Stück: 14

Manufacturer: Kenvue Austria GmbH

Product information "Nicorette 15 mg/16 h - transdermal patch"

View package leaflet

Nicorette 15 mg/16 h – transdermal patch is a medicinal product used to help people give up smoking. Nicorette contains nicotine as its active ingredient, which is released steadily and in a controlled manner through the skin into the body over a period of 16 hours.

The supply of nicotine via the Nicorette patch ensures that the withdrawal symptoms associated with nicotine withdrawal do not occur, or at least occur in a significantly milder form, thereby reducing the patient’s craving for cigarettes. These withdrawal symptoms primarily include irritability, restlessness, anxiety, increased appetite, difficulty concentrating and trouble falling asleep, which in many cases lead patients to take up smoking again. Nicorette acts as an aid and makes quitting easier, even in difficult cases, although appropriate motivation, willpower and perseverance are essential prerequisites for any smoking cessation programme.

Nicorette® transdermal patch can also be used as an aid for smokers during periods of temporary abstinence, when smoking is not possible or desirable.

Applying the Nicorette® transdermal patch whilst awake (for around 16 hours) is sufficient to effectively reduce withdrawal symptoms.

Advantages

Easy to use – just one patch a day is enough
Releases nicotine steadily throughout the day
Helps combat the urge to smoke and nicotine dependence
Worn for 16 hours, respecting the natural sleep-wake cycle

Dosage form

Transdermal patch

Directions for use

Smoking should be stopped completely whilst using Nicorette patches.

Smoking cessation with immediate cessation of smoking

Monotherapy

Adults and older people

The recommended dose is: The dosage should be based on the smoker’s level of tobacco dependence.

Smokers who are heavily dependent on tobacco (more than 20 cigarettes a day): Dosage regimen: heavy smokers (more than 20 cigarettes a day)

Phase 1: Nicorette 25 mg/16 h – transdermal patch for 8 weeks (duration of treatment)
Phase 2: Nicorette 15 mg/16 h – transdermal patch for 2 weeks (duration of use)
Phase 3 Nicorette 10 mg/16 h – transdermal patch for 2 weeks (duration of use)

Smokers with a lower level of tobacco dependence (up to and including 20 cigarettes a day): Dosage regimen: light smokers (up to and including 20 cigarettes a day)

Phase 2 Nicorette 15 mg/16 h – transdermal patch, 8 weeks (duration of use)
Phase 3 Nicorette 10 mg/16 h – transdermal patch, 4 weeks (duration of use)

Duration of treatment with monotherapy

The duration of treatment is 3 months. For some former smokers, longer treatment may be necessary to prevent a relapse into old smoking habits. Use of the patch for longer than 6 months is generally not recommended. In this case, you should consult your doctor.

Children and adolescents

Nicorette 25 mg/16 h transdermal patch should not be used in adolescents aged 12–18 years, as no data on safety and efficacy are available. In adolescents aged 12–18 years, the Nicorette 15 mg/16 h and 10 mg/16 h transdermal patches should only be used on the express recommendation of a doctor. There is only limited experience of treating this age group with Nicorette. Nicorette must not be used in children under 12 years of age.

Method of use

Each morning, immediately after getting up, remove the protective film and apply one patch as described below to a clean, dry, hairless and unbroken area of skin on the upper body, upper arm or hip. To do this, press the patch firmly against the skin for 10–15 seconds.

You should wash your hands before applying the patch.
Cut open the sachet with scissors along the marked line and remove the patch.
Peel off part of the silvery aluminium protective layer. Take care not to touch the adhesive side of the plaster with your fingers, so as not to reduce its adhesive properties.
Carefully apply the adhesive side of the plaster to a clean, dry, hairless and unbroken area of skin on the upper body, upper arm or hip. Then remove the second part of the silver aluminium protective layer.
Press the plaster firmly onto the skin with the palm of your hand or your fingertips.
Run your fingers firmly over the edges of the patch once more to ensure it adheres securely.

Note: You should then wash your hands thoroughly to prevent any nicotine accidentally left on your fingers from getting into your eyes.

Ingredients

The active ingredient is nicotine. 15 mg/16 h (size = 13.5 cm², contains 23.6 mg of nicotine).
The other ingredients are: medium-chain triglycerides, basic butyl methacrylate copolymer, polyethylene terephthalate film (PET); acrylate matrix: acrylic adhesive solution, potassium hydroxide, croscarmellose sodium, aluminium acetylacetonate; release film: polyethylene terephthalate film (PET) with one side aluminised and both sides siliconised; Printing ink: Two-component epoxy-amine ink for pharmaceutical applications.

Piece:	14

Instructions for use

Type of use:	Rauchen einstellen Täglich nach dem Aufstehen 1 Depot-Pflaster für 16 Stunden aufkleben, dann Pflaster entfernen Hautstelle wechseln
Field of use:	Unterstützung der Raucherentwöhnung bei Rauchern; Hilfsmittel für Raucher während temporärer Abstinenz
Dosage:	Starke Raucher über 20 Zigaretten pro Tag Tägl ein 25 mg-Pflaster über 8 Wochen, dann ein 15 mg- Pflaster über 2 Wochen und ein 10 mg-Pflaster über weitere 2 Wochen Schwache Raucher Tägl ein 15 mg-Pflaster über 8 Wochen, dann ein 10
Properties and efficacy:	Nikotin
Contraindications:	LogImport.sisx.GAD.Nichtraucher, Gelegenheitsraucher, Kinder
Habituation effects:	LogImport.sisx.GED.Übertragene Abhängigkeit auf Ersatzmittel möglich
Side effects:	Kopfschmerzen, Palpitationen, Übelkeit, Diarrhö, Haut, HerzKreislauf, Überempfindlichkeit, Vegetativum Symptome der Raucherentwöhnung Psyche, Vegetativum berücksichtigen
Special warnings for safe use:	Nur unter ärztlicher Aufsicht bei schweren kardiovaskulären Erkrankungen frischem Myokardinfarkt, instabiler Angina pectoris, schwere Arrhythmien, Schlaganfall, Phäochromozytom, Hyperthyreoidismus, Diabetes, Leber-, Nierenschäden, Ma
Interactions:	Interaktionen durch Beendigung des Rauchens möglich reduzierte CYP1A2-Aktivität Adenosin verstärkt
Pregnancy and breastfeeding period:	Vollständiger Rauchstopp empfohlen Nur nach medizinischer Empfehlung in der Schwangerschaft anwenden In der Stillzeit nicht anwenden Falls erforderlich Produkte mit flexibler Dosierung wie Kaugummi, Lutschtablette, Inhalationen, Spra

Pregnancy information

Use only if absolutely or vitally indicated
Use possible under careful supervision

Breastfeeding information

Breastfeeding forbidden
Breastfeeding only if absolutely or vitally indicated

Pictograms

Caution for diabetics

Product recommendations for you